5. Conclusion

Based on the results of this study [34], we can say that although the baseline concentrations of IL-6 in the patients of the problem group were higher in relation to those of the control group, the removal of this pro-inflammatory agent by MUF was statistically significant. This indicates that MUF is a procedure that can benefit pediatric patients with congenital heart disease undergoing CPB because it is able to decrease the concentration of IL-6. Therefore, we consider that the use of MUF in pediatric patients should be routinely recommended as long as hemodynamic conditions allow it.
